摘要
目的:介绍顺势疗法在南亚地区的发展现状,为我国学术界了解顺势疗法提供参考。方法:本文以History and Status of Homeopathy around the world《环球顺势疗法的历史和现状》为研究资料,从使用情况、教学情况、研究机构等方面,对顺势疗法在南亚地区的发展进行介绍。结果:南亚地区对顺势疗法进行立法的国家有印度、巴基斯坦、孟加拉国、尼泊尔和斯里兰卡。而将顺势疗法纳入医保的只有印度和巴基斯坦。印度的顺势疗法教学机构有182所,巴基斯坦有72所,孟加拉国有23所,尼泊尔有1所。拥有单独的顺势疗法法规的国家有印度、尼泊尔、巴基斯坦;拥有顺势疗法协会的国家有印度、尼泊尔、巴基斯坦和斯里兰卡。印度对顺势疗法开展过研究。印度是南亚地区中顺势疗法发展最全面的国家,且印度各邦亦有顺势疗法的相关机构。结论:顺势疗法在南亚地区比较受欢迎,尤其是在印度和巴基斯坦,其中顺势疗法在印度的发展时间最长,体系较为完善。
Objective:This paper introduces the development status of homeopathy in South Asia,and provides reference for Chinese academe to understand homeopathy.Methods:Based on the history and status of homeopathy around the world,this paper introduces the development of homeopathy in South Asia from the aspects of use,teaching and research institutions.Results:Countries in South Asia that have legislated homeopathy include India,Pakistan,Bangladesh,Nepal and Sri Lanka.Only India and Pakistan have included homeopathy in medical insurance.There are 182 homeopathic teaching institutions in India,72 in Pakistan,23 in Bangladesh and 1 in Nepal.Countries with independent homeopathic schools are India,Nepal and Pakistan.Countries with homeopathic associations include India,Nepal,Pakistan and Sri Lanka.India has conducted research on homeopathy.India is a country with the most comprehensive development of homeopathy among all countries in South Asia,and there are also relevant institutions of homeopathy in various Indian states.Conclusion:Homeopathy is popular in South Asia,especially in India and Pakistan,where homeopathy has the longest development time and a relatively complete system.
作者
李易
肖君晶
吴蕾
李晓莉
王张
LI Yi;XIAO Junjing;WU Lei;LI Xiaoli;WANG Zhang(School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan;School of Ethnic Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan;Research Institute of Traditional Indian Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan)
出处
《中药与临床》
2024年第4期125-129,共5页
Pharmacy and Clinics of Chinese Materia Medica
基金
科技部科技基础资源调查专项(2018FY100703)。
